Improving Care for Patients With Chronic Kidney Disease Using EMRALD

NCT02274298 | Unknown

• 1 other identifier: 074-2013-2
• Study Type: interventional
• Target: 221
• Locations: 0 countries
• Sites: N/A

Brief Summary

This pragmatic cluster randomized controlled trial will test the impact of feedback and a toolkit aimed at improving the management of chronic kidney disease (CKD) in the primary care setting. This trial will use family physicians in Ontario participating in the Electronic.

Conditions

Chronic Kidney Disease

Outcome Measures

Primary Outcomes (1)

• Proportion of patients age 50-80 with Stage 3+ CKD and a statin prescription

  Comparison of proportion of patients age 50-80 years with Stage 3+ CKD (no dialysis or renal transplant) and receiving a statin prescription at baseline and at the end of the trial

  24 months

Secondary Outcomes (6)

• Proportion of patients at high risk screened for CKD with an eGFR and/or ACR

  24 months

• Proportion of patients with an initial eGFR <60 and a f/u eGFR or an ACR

  24 months

• Proportion of patients with diabetes and albuminuria and on an ACE or ARB

  24 months

• Proportion of patients meeting eGFR criteria for CKD and documentation of CKD in the cumulative patient profile (CPP)

  24 months

• Proportion of patients with an ACR in the past 18 months and meeting bp targets

  24 months

Study Arms (2)

CKD feedback and tools

ACTIVE COMPARATOR

Physicians in these clinics/clusters will receive feedback on their performance for screening and managing CKD quality indicators as well as EMR tools to aid in their performance

Behavioral: CKD feedback and tools

No Intervention

NO INTERVENTION

Physicians in these clinics/clusters will not receive CKD feedback or tools

Interventions

CKD feedback and tools BEHAVIORAL

people in the intervention arm will receive feedback on ckd quality indicators and tools to help in the detection and management of ckd

CKD feedback and tools

Eligibility Criteria

• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Family physicians participating in EMRALD, on the EMR for \>=2 years, roster size \>=100 patients
• Patient criteria, rostered and actively seeing an EMRALD physician, on the EMR for .=1 year

You may not qualify if:

• Updated data available at the time of study commencement

Sponsors & Collaborators

• Sunnybrook Health Sciences Centre: lead
• Ontario Renal Network: collaborator

Related Publications (1)

• Nash DM, Ivers NM, Young J, Jaakkimainen RL, Garg AX, Tu K. Improving Care for Patients With or at Risk for Chronic Kidney Disease Using Electronic Medical Record Interventions: A Pragmatic Cluster-Randomized Trial Protocol. Can J Kidney Health Dis. 2017 Apr 5;4:2054358117699833. doi: 10.1177/2054358117699833. eCollection 2017.

  PMID: 28607686 DERIVED

MeSH Terms

Conditions

Renal Insufficiency, Chronic

Condition Hierarchy (Ancestors)

Renal Insufficiency; Kidney Diseases; Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Male Urogenital Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Karen Tu, MD, MSc

  ICES/Sunnybrook

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Senior Scientist

Study Record Dates

• First Submitted: October 6, 2014
• First Posted: October 24, 2014
• Study Start: October 1, 2014
• Primary Completion: April 1, 2017
• Study Completion: April 1, 2017
• Last Updated: October 14, 2016

Record last verified: 2016-10

Data Sharing

• IPD Sharing: Will not share